Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics 2025
Hybrid Event
Oct 16 - 17, 2025
Las Vegas, Nevada, USA
16.25 AMA PRA Category 1 Credits™ ...Speakers
OVERVIEW
Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics is organized by CME Science and will be held from Oct 16 - 17, 2025 at Wynn Las Vegas, Las Vegas, Nevada, United States of America.
Description:
This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.
At the conclusion of this course, participants will be able to:
- Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT
- Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice
- Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging
- Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT
With the recent approval by CMS Medicare for DOTATATE (NETSPOT) PET/CT and the rapid international adoption of targeted Lu-177 based therapies for neuroendocrine and prostate cancers, it is clear that Nuclear Medicine and PET/CT are entering into a new era. New diagnostic and therapeutic agents with remarkable sensitivity and specificity are revolutionizing Nuclear Medicine and Oncology. This course will highlight the latest targeted imaging agents for neuroendocrine and prostate cancers (Ga-68 DOTATATE and Ga-68 PSMA PET/CT) as well as review important core concepts in PET/CT imaging and therapeutic Nuclear Medicine.
KEY DATES
16 Oct, 2025
Event Start Date
17 Oct, 2025
Event End Date
ACCREDITATION & CREDITS
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and CME Science. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Partners designates this live activity for 16.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Technologists: This course is pending approval for up to 16 ARRT Category A CE credits for those technologists attending the entire course (pending courses are always approved but the official language requires we use “pending approval” until closer to the course start date).
TARGET AUDIENCE
PhysicianPhysician AssistantOncologyScientistsRadiologistsNurseResidentsNursesMedical TechnologistRadiology TechniciansNuclear Medicine PhysiciansFellowsSPECIALITIES
Nuclear MedicineRadiologyDiagnostic RadiologyOncologyNeurologySUGGESTED HOTELS
CONFERENCE VENUE
Wynn Las VegasCANCELLATION & REFUND POLICY
Cancellations received at least 30 days in advance are subject to a $100 cancellation fee or may be exchanged for their full value for a voucher for future use for any live, webinar, or on-demand course that takes place within 13 months of the canceled course. Cancellations received less than 30 days before the start of the course are non-refundable but may be exchanged for their full value for a voucher for future use for any live, webinar, or on-demand course that takes place within 13 months of the canceled course.
RELATED CONFERENCES & LIVE WEBINARS
Quick Links